Zum Inhalt springen

Chromogranin A Linked to Cognitive Resilience in Alzheimer’s Brain Changes

Researchers identify a molecular signature distinguishing asymptomatic from symptomatic Alzheimer’s

Some people show clear Alzheimer’s brain changes yet remain cognitively intact, puzzling researchers who expected memory loss to follow pathology. Researchers identify a molecular signature distinguishing asymptomatic from symptomatic Alzheimer’s Scientists at the University of California San Diego analyzed gene activity in thousands of human brain samples using a custom AI method to differentiate healthy … Weiterlesen …

UCSD Study Finds Chromogranin A May Protect Brain From Alzheimer’s Symptoms in Some People

How asymptomatic Alzheimer’s differs from symptomatic cases

Researchers at the University of California San Diego found that 20 to 30 percent of people with Alzheimer’s brain changes indicate no memory loss or cognitive decline. How asymptomatic Alzheimer’s differs from symptomatic cases The team analyzed gene activity in thousands of human brain samples using a custom AI tool to distinguish healthy aging, symptomatic … Weiterlesen …

Blood Tests and AI Sleep Analysis Predict Alzheimer’s Risk 20 Years Early

Blood biomarkers are outperforming traditional brain scans

New blood tests and AI-driven sleep analyses can now identify Alzheimer’s risk up to 20 years before a patient shows a single clinical symptom. Data released in April 2026 confirms that early detection has reached market maturity, shifting the diagnostic window from reacting to memory loss to predicting pathology in healthy adults. The pTau217 Marker … Weiterlesen …